PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1120992
PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1120992
Europe Prothrombin Complex Concentrate Market, By Type ; By End-User, By Application, By Country ; Trend Analysis, Competitive Market Share & Forecast, 2018-2028
Europe Prothrombin Complex Concentrate Market to Reach USD 409.5 Million by 2028
Europe's prothrombin complex concentrate market is growing owing to increasing instances of warfarin-associated bleeding disorders, the frequency of coagulation factor disorders, and people's rising income levels coupled with factors like less time required to administer and several benefits over other alternative anticoagulation-reversal therapies such as Fresh Frozen Plasma.
A recent study by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the Europe prothrombin complex concentrate market was worth USD 197.1 million in 2021. The market is projected to grow at a CAGR of 11.2%, earning around USD 409.5 billion in revenues by 2028. The Europe prothrombin complex concentrate market is booming due to less administration time and several advantages over alternative anticoagulation-reversal therapies such as Fresh Frozen Plasma. Moreover, factors like an increase in warfarin-associated bleeding disorders, the frequency of coagulation factor disorders, and people's rising income levels propel the Europe prothrombin complex concentrate Market.
Growing Geriatric Populations In Europe Coupled With the Development Of Anticoagulation Clinics Will Open Up Market Opportunities
The continent's growing aging population is one new reason for boosting Europe's prothrombin complex concentrate industry. The UN Population Division's most recent statistics show that nearly 25% of Europeans are 60 years of age or older. Additionally, according to projections from the European Commission (EC), the proportion of EU-27 inhabitants over the age of 80 will increase from 5.8% to 14.6% between 2019 and 2100. Acute liver injury is more likely to occur in older people and is also more susceptible to the fibrotic response. Patients with the liver disease usually develop coagulopathy, making prothrombin complex concentrate an extremely efficient treatment. Researchers from the Royal Free Hospital in London and University College London discovered that PCC therapy improved coagulation test results in individuals with liver illness without causing an excessive number of thrombotic events in a 2019 study they conducted. The effectiveness of PCC treatments and an increase in the number of elderly people will improve the market's prospects in Europe.
As the use of oral anticoagulants and warfarin has greatly expanded, the emergence of anticoagulation care clinics has entered a phase of the treatment of bleeding disorders. The concept of warfarin clinics is gaining popularity in affluent countries of Europe. Owing to the notable variations in intrapatient & interpatient responses during warfarin administration, as well as the availability of skilled medical personnel and well-equipped infrastructure.
Acquired Coagulation Factor Accounted For The Largest Market Share in Terms of Application
Application-wise, the acquired coagulation factor deficiency market sector is anticipated to develop at the fastest CAGR and hold dominance. Warfarin prescription rates in the U.K. are rising, and defined guidelines for PCC dose schedules in the event of warfarin-related bleeding events are projected to support this segment's growth during the projection period. For instance, according to study results published by the National Center of Biotechnology Information (NCBI) in the UK, it has been discovered that at least 1% of the general population and 8% of persons over the age of 80 take warfarin. The acquired coagulation factor deficiency market is also anticipated to show promising growth over the forecast period.
Germany and France Anticipated to Lead the Europe Prothrombin Complex Concentrate Market
On the basis of country, the Europe prothrombin complex concentrate market is divided into Germany, the United Kingdom, Italy, France, The Netherlands, Belgium, Russia, Spain, Poland, Portugal, Austria, and the Rest of Europe. Germany and France are anticipated to lead the Europe PCC market due to a sizable patient pool with congenital factor IX deficiency. On the other side, the U.K. is anticipated to grow at the fastest rate during the forecast period due to the country's rising prevalence of haemophilia B. This is expected to increase the adoption of PCC throughout Europe. The PCC market in the rest of europe is expanding due to CSL Behring's PCC brand Confidex's established operations there and its use to treat both acquired and congenital coagulation factor deficiency. The high demand for the Uman Complex D.I., a 3-factor PCC by Kendrion, in Italy, the rise in bleeding disorders, and the dominance of large PCC producers all have an impact on the chance that France and Italy will develop at a consistent rate.
Impact of COVID-19 on Europe Prothrombin Complex Concentrate Market
The COVID-19 outbreak had no noticeable effect on expanding the prothrombin complex concentrate market. The demand for blood and plasma products has abruptly increased due to the COVID-19 pandemic. According to major PCC manufacturers, the prothrombin complex concentrate market has been favored by changes in the purchasing habits of plasma-derived products. Due to higher plasma center productivity and Kcentra's double-digit growth, pharmaceutical companies like Grifols and CSL are also experiencing an increase in segmental revenue. On the market as a whole, this is anticipated to have a favorable effect on Europe prothrombin complex concentrate market.
Competitive Landscape
The Europe prothrombin complex concentrate market is fragmented, with numerous players serving the market. The key players dominating in the Europe region are CSL Behring GmbH, OCTA Pharma AG, Kedrion S.P.A., Takeda Pharmaceuticals, China Biologic Products, Sanquin, Grifols S.A, Biotest, Abeona Therapeutics, Insud Pharma and Other Prominent Players. Facilities growth, product diversification, alliances, collaborations, partnerships, and acquisition are the main marketing strategies used by the players to increase their customer base and acquire a competitive advantage in the overall market.
The report's in-depth analysis provides information about growth potential, upcoming trends, and statistics of the Europe Prothrombin Complex Concentrate market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Europe Prothrombin Complex Concentrate market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the market's growth drivers, challenges, and competitive dynamics.
Table of Contents
1. Research Framework
- 1.1. Research Objective
- 1.2. Product Overview
- 1.3. Market Segmentation
2. Research Methodology
- 2.1. Qualitative Research
- 2.1.1. Primary & Secondary Research
- 2.2. Quantitative Research
- 2.3. Market Breakdown & Data Triangulation
- 2.3.1. Secondary Research
- 2.3.2. Primary Research
- 2.4. Breakdown of Primary Research Respondents, By Region
- 2.5. Assumption & Limitation
3. Executive Summary
4. Europe Prothrombin Complex Concentrate Market Insights
- 4.1. Industry Value Chain Analysis
- 4.2. DROC Analysis
- 4.2.1. Growth Drivers
- 4.2.2. Restraints
- 4.2.3. Opportunities
- 4.2.4. Challenges
- 4.3. Technological Landscape/Recent Development
- 4.4. Regulatory Framework
- 4.5. Porter's Five Forces Analysis
- 4.5.1. Bargaining Power of Suppliers
- 4.5.2. Bargaining Power of Buyers
- 4.5.3. Threat of New Entrants
- 4.5.4. Threat of Substitutes
- 4.5.5. Intensity of Rivalry
5. Europe Prothrombin Complex Concentrate Market Overview
- 5.1. Market Size & Forecast by Value, 2018-2028
- 5.1.1. By Value (USD Million)
- 5.2. Market Share & Forecast
- 5.2.1. By Type
- 5.2.1.1. 3-Factor
- 5.2.1.2. 4-Factor
- 5.2.2. By End-User
- 5.2.2.1. Hospital
- 5.2.2.2. Ambulatory Services
- 5.2.2.3. Others
- 5.2.3. By Application
- 5.2.3.1. Acquired Coagulation Factor Deficiency
- 5.2.3.2. Congenital Coagulation Factor Deficiency
- 5.2.3.3. Others
- 5.2.4. By Country
- 5.2.4.1. Germany
- 5.2.4.2. United Kingdom
- 5.2.4.3. Italy
- 5.2.4.4. France
- 5.2.4.5. Spain
- 5.2.4.6. The Netherlands
- 5.2.4.7. Belgium
- 5.2.4.8. Russia
- 5.2.4.9. Poland
- 5.2.4.10. Portugal
- 5.2.4.11. Austria
- 5.2.4.12. Rest of Europe
- 5.2.1. By Type
6. Germany Prothrombin Complex Concentrate Market
- 6.1. Market Size & Forecast by Value, 2018-2028
- 6.1.1. By Value (USD Million)
- 6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By End-User
- 6.2.3. By Application
7. United Kingdom Prothrombin Complex Concentrate Market
- 7.1. Market Size & Forecast by Value, 2018-2028
- 7.1.1. By Value (USD Million)
- 7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By End-User
- 7.2.3. By Application
8. Italy Prothrombin Complex Concentrate Market
- 8.1. Market Size & Forecast by Value, 2018-2028
- 8.1.1. By Value (USD Million)
- 8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By End-User
- 8.2.3. By Application
9. France Prothrombin Complex Concentrate Market
- 9.1. Market Size & Forecast by Value, 2018-2028
- 9.1.1. By Value (USD Million)
- 9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By End-User
- 9.2.3. By Application
10. Spain Prothrombin Complex Concentrate Market
- 10.1. Market Size & Forecast by Value, 2018-2028
- 10.1.1. By Value (USD Million)
- 10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By End-User
- 10.2.3. By Application
11. The Netherlands Prothrombin Complex Concentrate Market
- 11.1. Market Size & Forecast by Value, 2018-2028
- 11.1.1. By Value (USD Million)
- 11.2. Market Share & Forecast
- 11.2.1. By Type
- 11.2.2. By End-User
- 11.2.3. By Application
12. Belgium Prothrombin Complex Concentrate Market
- 12.1. Market Size & Forecast by Value, 2018-2028
- 12.1.1. By Value (USD Million)
- 12.2. Market Share & Forecast
- 12.2.1. By Type
- 12.2.2. By End-User
- 12.2.3. By Application
13. Russia Prothrombin Complex Concentrate Market
- 13.1. Market Size & Forecast by Value, 2018-2028
- 13.1.1. By Value (USD Million)
- 13.2. Market Share & Forecast
- 13.2.1. By Type
- 13.2.2. By End-User
- 13.2.3. By Application
14. Poland Prothrombin Complex Concentrate Market
- 14.1. Market Size & Forecast by Value, 2018-2028
- 14.1.1. By Value (USD Million)
- 14.2. Market Share & Forecast
- 14.2.1. By Type
- 14.2.2. By End-User
- 14.2.3. By Application
15. Portugal Prothrombin Complex Concentrate Market
- 15.1. Market Size & Forecast by Value, 2018-2028
- 15.1.1. By Value (USD Million)
- 15.2. Market Share & Forecast
- 15.2.1. By Type
- 15.2.2. By End-User
- 15.2.3. By Application
16. Austria Prothrombin Complex Concentrate Market
- 16.1. Market Size & Forecast by Value, 2018-2028
- 16.1.1. By Value (USD Million)
- 16.2. Market Share & Forecast
- 16.2.1. By Type
- 16.2.2. By End-User
- 16.2.3. By Application
17. Rest of the Europe Prothrombin Complex Concentrate Market
- 17.1. Market Size & Forecast by Value, 2018-2028
- 17.1.1. By Value (USD Million)
- 17.2. Market Share & Forecast
- 17.2.1. By Type
- 17.2.2. By End-User
- 17.2.3. By Application
18. Competitive Landscape
- 18.1. List of Key Players and Their Offerings
- 18.2. Market Share Analysis, 2021
- 18.3. Competitive Benchmarking, By Operating Parameters
- 18.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)
19. Impact of COVID-19 on Europe Prothrombin Complex Concentrate Market
20. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)
- 20.1. CSL Behring GmbH
- 20.2. OCTA Pharma AG
- 20.3. Kedrion S.P.A.
- 20.4. Takeda Pharmaceuticals
- 20.5. China Biologic Products
- 20.6. Sanquin
- 20.7. Grifols S.A
- 20.8. Biotest
- 20.9. Abeona Therapeutics
- 20.10. Insud Pharma
- 20.11. Other Prominent Players
21. Key Strategic Recommendations
Note: Financial in information in case of non-listed companies will be provided as per availability
The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
List of Figures
- Figure 1: Europe Prothrombin Complex Concentrate Market Segmentation
- Figure 2: Europe Prothrombin Complex Concentrate Market Industry Value Chain Analysis
- Figure 3: Europe Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
- Figure 4: Europe Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
- Figure 5: Europe Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
- Figure 6: Europe Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
- Figure 7: Europe Prothrombin Complex Concentrate Market Share (%), By Country, By Value, 2018-2028
- Figure 8: Germany Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
- Figure 9: Germany Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
- Figure 10: Germany Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
- Figure 11: Germany Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
- Figure 12: United Kingdom Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
- Figure 13: United Kingdom Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
- Figure 14: United Kingdom Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
- Figure 15: United Kingdom Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
- Figure 16: Italy Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
- Figure 17: Italy Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
- Figure 18: Italy Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
- Figure 19: Italy Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
- Figure 20: France Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
- Figure 21: France Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
- Figure 22: France Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
- Figure 23: France Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
- Figure 24: Spain Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
- Figure 25: Spain Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
- Figure 26: Spain Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
- Figure 27: Spain Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
- Figure 28: The Netherlands Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
- Figure 29: The Netherlands Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
- Figure 30: The Netherlands Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
- Figure 31: The Netherlands Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
- Figure 32: Belgium Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
- Figure 33: Belgium Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
- Figure 34: Belgium Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
- Figure 35: Belgium Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
- Figure 36: Russia Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
- Figure 37: Russia Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
- Figure 38: Russia Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
- Figure 39: Russia Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
- Figure 40: Poland Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
- Figure 41: Poland Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
- Figure 42: Poland Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
- Figure 43: Poland Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
- Figure 44: Portugal Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
- Figure 45: Portugal Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
- Figure 46: Portugal Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
- Figure 47: Portugal Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
- Figure 48: Austria Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
- Figure 49: Austria Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
- Figure 50: Austria Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
- Figure 51: Austria Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
- Figure 52: Rest of the Europe Prothrombin Complex Concentrate Market Size, By Value (USD Million), 2018-2028
- Figure 53: Rest of the Europe Prothrombin Complex Concentrate Market Share (%), By Type, By Value, 2018-2028
- Figure 54: Rest of the Europe Prothrombin Complex Concentrate Market Share (%), By End-User, By Value, 2018-2028
- Figure 55: Rest of the Europe Prothrombin Complex Concentrate Market Share (%), By Application, By Value, 2018-2028
- Figure 56: Europe Prothrombin Complex Concentrate Market Share Analysis, 2021
List of Tables
- Table 1: Europe Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
- Table 2: Europe Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
- Table 3: Europe Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
- Table 4: Europe Prothrombin Complex Concentrate Market Size. By Region, By Value (USD Million), 2018-2028
- Table 5: Germany Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
- Table 6: Germany Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
- Table 7: Germany Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
- Table 8: United Kingdom Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
- Table 9: United Kingdom Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
- Table 10: United Kingdom Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
- Table 11: Italy Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
- Table 12: Italy Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
- Table 13: Italy Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
- Table 14: France Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
- Table 15: France Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
- Table 16: France Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
- Table 17: Spain Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
- Table 18: Spain Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
- Table 19: Spain Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
- Table 20: The Netherlands Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
- Table 21: The Netherlands Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
- Table 22: The Netherlands Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
- Table 23: Belgium Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
- Table 24: Belgium Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
- Table 25: Belgium Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
- Table 26: Russia Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
- Table 27: Russia Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
- Table 28: Russia Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
- Table 29: Poland Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
- Table 30: Poland Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
- Table 31: Poland Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
- Table 32: Portugal Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
- Table 33: Portugal Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
- Table 34: Portugal Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
- Table 35: Austria Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
- Table 36: Austria Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
- Table 37: Austria Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
- Table 38: Rest of the Europe Prothrombin Complex Concentrate Market Size, By Type, By Value (USD Million), 2018-2028
- Table 39: Rest of the Europe Prothrombin Complex Concentrate Market Size, By End-User, By Value (USD Million), 2018-2028
- Table 40: Rest of the Europe Prothrombin Complex Concentrate Market Size, By Application, By Value (USD Million), 2018-2028
- Table 41: List of Key Players and Their Offerings
- Table 42: Competitive Benchmarking, by Operating Parameters
- Table 43: CSL Behring GmbH Company Overview
- Table 44: CSL Behring GmbH Financial Overview
- Table 45: OCTA Pharma AG Company Overview
- Table 46: OCTA Pharma AG Financial Overview
- Table 47: Kedrion S.P.A. Company Overview
- Table 48: Kedrion S.P.A. Financial Overview
- Table 49: Takeda Pharmaceuticals Company Overview
- Table 50: Takeda Pharmaceuticals Financial Overview
- Table 51: China Biologic Products Company Overview
- Table 52: China Biologic Products Financial Overview
- Table 53: Sanquin Company Overview
- Table 54: Sanquin Financial Overview
- Table 55: Grifols S.A company Overview
- Table 56: Grifols S.A Financial Overview
- Table 57: Biotest Company Overview
- Table 58: Biotest Financial Overview
- Table 59: Abeona Therapeutics Company Overview
- Table 60: Abeona Therapeutics Financial Overview
- Table 61: Insud Pharma Company Overview
- Table 62: Insud Pharma Financial Overview
